Serum hepcidin levels at the time of breast cancer diagnosis may serve as a pivotal predictive indicator of disease severity, prognosis, recurrence, and overall survival, with elevated levels indicative of heightened recurrence risk and diminished overall survival. The gene discussed is HAMP; the disease is breast cancer.